Silo Pharma(SILO.US) Officer Buys US$5,533.14 in Common Stock
$Silo Pharma(SILO.US)$ Officer Weisblum Eric purchased 5,000 shares of common stock on Jun 11, 12, 2024 at an average price of $1.11 for a total value of $5,533.14.Source: Announcement What is stateme
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersViracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Purple Biotech (NASDAQ:PPBT) stock in
Silo Pharma Close to Achieving Optimal Formulation for Ketamine Implant
Silo Pharma (SILO) said Friday it has moved closer to achieving the optimal formulation for its SP-26 ketamine implant to treat chronic pain and fibromyalgia. The developmental stage biopharmaceutical
Express News | Silo Pharma Announces Successful Development Milestones For SP-26 Ketamine Implant Therapeutic Targeting Fibromyalgia And Chronic Pain
Express News | Silo Pharma Announces Successful Production of Its SP-26 Ketamine Implant for Fibromyalgia
Express News | Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Top Midday Decliners
SPAR Group (SGRP) said Wednesday that it has entered into a letter of intent to go private with Highwire Capital. Shares slumped nearly 24%, with intraday trading volume at almost 823,900 versus a dai
Why Silo Pharma Stock Is Down Over 30%
Silo Pharma Inc (NASDAQ:SILO) shares are trading lower by 31% to $1.55 during Wednesday's session after the company announced it has entered into agreements to sell 917,432 shares of common stock at $
Express News | Silo Pharma Shares Are Trading Lower After the Company Announced a $2 Million Registered Direct Offering
Express News | Silo Pharma Enters Agreements For Purchase And Sale Of 917,432 Shares At $2.18/Share In A Registered Direct Offering; Gross Proceeds $2M
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersENDRA Life Sciences (NASDAQ:NDRA) stock increased by 71.6% to $0.15 during Wednesday's pre-market session. The company's market cap stands at $1.5 million. Concord Medical Services (NYSE:CCM) s
Silo Pharma to Use Net Proceeds From the Offering for Working Cap, General Corporate Purposes >SILO
Silo Pharma to Use Net Proceeds From the Offering for Working Cap, General Corporate Purposes >SILO
Silo Pharma to Place 917,432 Shares of Common Stock at $2.18 Per Share >SILO
Silo Pharma to Place 917,432 Shares of Common Stock at $2.18 Per Share >SILO
Express News | Silo Pharma Announces $2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Sector Update: Health Care Stocks Rise Tuesday Afternoon
Health care stocks rose Tuesday afternoon with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) was little changed,
Express News | Silo Pharma Shares Are Trading Higher After the Company Announced Its Submission of a Pre-Investigational New Drug Briefing Package and Meeting Request to the FDA for SPC-15 as a Treatment for PTSD and Anxiety
Express News | Silo Pharma-in Accordance With Sponsored Research Deal, Co to Be Granted Exclusive License to Further Develop,Commercialize Spc-15 Worldwide
Express News | Silo Pharma Submits Pre-Investigational New Drug Application to FDA for Spc-15 as a Treatment for Ptsd and Anxiety
Jaguar Health, Altamira Therapeutics,Erasca Among Healthcare Movers
Express News | Silo Pharma - Under Terms of License Agreement, to Be Granted Exclusive License to Further Develop, Manufacture, and Commercialize Spc-15 Worldwide
No Data